Literature DB >> 21784892

Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.

Paolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21784892     DOI： 10.1681/ASN.2011060610

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

Review 1.  Changing the concepts of immune-mediated glomerular diseases through proteomics.

Authors:  Dawn J Caster; Liliane Hobeika; Jon B Klein; David W Powell; Kenneth R McLeish
Journal:  Proteomics Clin Appl       Date:  2015-06-17       Impact factor: 3.494

2.  Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis.

Authors:  Weiying Li; Yuliang Zhao
Journal:  Int Urol Nephrol       Date:  2019-05-28       Impact factor: 2.370

3.  Rituximab in idiopathic membranous nephropathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Antonietta Chianca; Annalisa Perna; Barbara Ruggiero; Flavio Gaspari; Alessandro Rambaldi; Maddalena Marasà; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

Review 4.  The primary glomerulonephritides: a systems biology approach.

Authors:  Song Jiang; Peter Y Chuang; Zhi-Hong Liu; John C He
Journal:  Nat Rev Nephrol       Date:  2013-07-16       Impact factor: 28.314

5.  Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.

Authors:  Shane A Bobart; Heedeok Han; Shahrzad Tehranian; An S De Vriese; Juan Carlos Leon Roman; Sanjeev Sethi; Ladan Zand; Cristina Andrades Gomez; Callen D Giesen; Maria Jose Soler; Andrew S Bomback; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-15       Impact factor: 8.237

6.  Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy.

Authors:  Rebecca I Spain; Nicole K Andeen; Pamela C Gibson; Mary H Samuels; Cynthia D Morris; Andrew J Solomon; Richard Solomon; Carin Waslo; Rupali S Avasare
Journal:  Kidney Int       Date:  2021-10-16       Impact factor: 10.612

7.  Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population.

Authors:  Mohammadreza Ardalan; Ali Ghafari; Fatemeh Hamzavi; Hamid Nasri; Behrooz Baradaran; Jafar Majidi; Behrooz Nikbin
Journal:  J Nephropathol       Date:  2013-10-01

8.  Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Authors:  Piero Ruggenenti; Hanna Debiec; Barbara Ruggiero; Antonietta Chianca; Timothee Pellé; Flavio Gaspari; Flavio Suardi; Elena Gagliardini; Silvia Orisio; Ariela Benigni; Pierre Ronco; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

9.  Triggers, bullets and targets, puzzle of membranous nephropathy.

Authors:  Mohammadreza Ardalan
Journal:  Nephrourol Mon       Date:  2012-09-24

10.  Receptor antibody time-resolved A2 phospholipase bead immunochromatography and its application in idiopathic membranous nephropathy.

Authors:  Biao Huang; Xue Yang; Wenchen Zhang; Jian Wu; Pengfei Liu; Zhigang Hu; Tingting Wang
Journal:  J Clin Lab Anal       Date:  2020-08-06       Impact factor: 3.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.